Literature DB >> 17145154

Cirrhosis: CT and MR imaging evaluation.

Giuseppe Brancatelli1, Michael P Federle, Roberta Ambrosini, Roberto Lagalla, Alessandro Carriero, Massimo Midiri, Valérie Vilgrain.   

Abstract

In this article, we present the CT and MR imaging characteristics of the cirrhotic liver. We describe the altered liver morphology in different forms of viral, alcoholic and autoimmune end-stage liver disease. We present the spectrum of imaging findings in portal hypertension, such as splenomegaly, ascites and varices. We describe the patchy and lacelike patterns of fibrosis, along with the focal confluent form. The process of hepatocarcinogenesis is detailed, from regenerative to dysplastic nodules to overt hepatocellular carcinoma. Different types of non-neoplastic focal liver lesions occurring in the cirrhotic liver are discussed, including arterially enhancing nodules, hemangiomas and peribiliary cysts. We show different conditions causing liver morphology changes that can mimic cirrhosis, such as congenital hepatic fibrosis, "pseudo-cirrhosis" due to breast metastases treated with chemotherapy, Budd-Chiari syndrome, sarcoidosis and cavernous transformation of the portal vein.

Entities:  

Mesh:

Year:  2006        PMID: 17145154     DOI: 10.1016/j.ejrad.2006.11.003

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  37 in total

Review 1.  Four-dimensional flow magnetic resonance imaging in cirrhosis.

Authors:  Zoran Stankovic
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

2.  Can functional parameters from hepatobiliary phase of gadoxetate MRI predict clinical outcomes in patients with cirrhosis?

Authors:  Kumar Sandrasegaran; Enming Cui; Reem Elkady; Pauley Gasparis; Gitasree Borthakur; Mark Tann; Suthat Liangpunsakul
Journal:  Eur Radiol       Date:  2018-04-12       Impact factor: 5.315

3.  MR imaging features of liver involvement by Wilson disease in adult patients.

Authors:  Ottavia Vargas; Sid Ahmed Faraoun; Raphael Dautry; Youcef Guerrache; France Woimant; Lounis Hamzi; Mourad Boudiaf; Aurelia Poujois; Philippe Soyer; Anthony Dohan
Journal:  Radiol Med       Date:  2016-04-22       Impact factor: 3.469

4.  Segmental hypertrophy mimicking liver tumor in a patient with primary sclerosing cholangitis.

Authors:  Michael Oster; Saif Abu-Mouch; Alicia Nachtigal; Ahmad Mahamid; Abdel-Rauf Zeina
Journal:  J Gastrointest Cancer       Date:  2015-03

5.  Impaired visibility of the hepatic veins on the multi-detector computed tomography in patients with cirrhosis.

Authors:  Nilgun Isiksalan Ozbulbul; Mehmet Yurdakul; Muharrem Tola
Journal:  Eurasian J Med       Date:  2014-10

Review 6.  General Pitfalls in Imaging of Patients With Cirrhosis.

Authors:  Ali Morshid; Victoria Chernyak; Alice W Fung; Khaled Elsayes
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-04-13

7.  Hepatic pathology after Fontan palliation: spectrum of imaging findings.

Authors:  Daniel B Wallihan; Daniel J Podberesky
Journal:  Pediatr Radiol       Date:  2012-10-06

8.  Diagnostic performance of quantitative magnetic resonance imaging biomarkers for predicting portal hypertension in children and young adults with autoimmune liver disease.

Authors:  Jonathan R Dillman; Suraj D Serai; Andrew T Trout; Ruchi Singh; Jean A Tkach; Amy E Taylor; Burns C Blaxall; Lin Fei; Alexander G Miethke
Journal:  Pediatr Radiol       Date:  2019-01-03

Review 9.  Putting it all together: established and emerging MRI techniques for detecting and measuring liver fibrosis.

Authors:  Suraj D Serai; Andrew T Trout; Alexander Miethke; Eric Diaz; Stavra A Xanthakos; Jonathan R Dillman
Journal:  Pediatr Radiol       Date:  2018-08-04

10.  Role of surgical resection for multiple hepatocellular carcinomas.

Authors:  Sung Hoon Choi; Gi Hong Choi; Seung Up Kim; Jun Yong Park; Dong Jin Joo; Man Ki Ju; Myoung Soo Kim; Jin Sub Choi; Kwang Hyub Han; Soon Il Kim
Journal:  World J Gastroenterol       Date:  2013-01-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.